Atlas Trials

Stellate Ganglion Block With Lidocaine for the Treatment of COVID-19-Induced Parosmia

Clinical trial NCT06055270 · UNKNOWN

Trial details

NCT number
NCT06055270
Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Parosmia
Start date
2024-02-15
Primary completion
2025-12-24
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.